Data / Form D filings / Biodexa Pharmaceuticals Plc
Biodexa Pharmaceuticals Plc: Form D filings
Biodexa Pharmaceuticals Plc, a pharmaceuticals company in Cardiff, United Kingdom, filed 6 Form D notices with the SEC between 2019 and 2024. The latest, on August 1, 2024, reports $5 million sold of a $5 million offering to 7 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 1 CASPIAN POINT, CASPIAN WAY, Cardiff, United Kingdom, CF10
- Phone
- 44 (0)1235 888300
- Industry
- Pharmaceuticals
- Entity type
- Other (Public limited company organized under the laws of England and Wales.)
- Incorporated in
- United Kingdom
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1643918
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 1, 2024 | New notice | $5,009,968 | $5,009,968 | 7 | Jul 19, 2024 | sec.gov | |
| Jan 4, 2024 | New notice | $6,793,406 | $6,793,406 | 1 | Dec 21, 2023 | sec.gov | |
| Jun 7, 2023 | New notice | $3,320,388 | $3,320,388 | 15 | May 23, 2023 | sec.gov | |
| Feb 17, 2023 | New notice | $5,999,223 | $5,999,223 | 6 | Feb 9, 2023 | sec.gov | |
| Jun 4, 2020 | New notice | $3,000,000 | $3,000,000 | 7 | May 18, 2020 | sec.gov | |
| Nov 7, 2019 | New notice | $3,000,000 | $3,000,000 | 1 | Oct 22, 2019 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Stephen Stamp | Executive Officer, Director | |
| Simon Turton | Director | |
| Stephen Parker | Director | |
| Sijmen de Vries | Director | |
| Ann Merchant | Executive Officer |
Every Form D from the week of Jul 29, 2024 · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Biodexa Pharmaceuticals Plc reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.